Literature DB >> 6933888

Marked hypophosphatemia associated with acute myelomonocytic leukemia. Indirect evidence of phosphorus uptake by leukemic cells.

K W Zamkoff, J J Kirshner.   

Abstract

A 51-year-man was seen with the diagnosis of acute myelomonocytic leukemia. The WBC count was 380,000/microL at presentation. The serum phosphorus concentration was 0.4 mg/dL and 0.2 mg/dL prior to any phosphorus replacement. Urinary phosphorus excretion was too low to be measured. The patient did not demonstrate any of the usual causes of profound hypophosphatemia with hypophosphaturia. The parathyroid glands were normal at necropsy. Reasons for believing the profound hypophosphatemia was due to phosphorus uptake by the leukemic cells are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6933888

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Incidence of hypophosphatemia in advanced cancer patients: a recent report from a single institution.

Authors:  Taichi Yoshida; Daiki Taguchi; Koji Fukuda; Kazuhiro Shimazu; Masahiro Inoue; Katsunori Murata; Hiroyuki Shibata
Journal:  Int J Clin Oncol       Date:  2016-11-10       Impact factor: 3.402

Review 2.  Kidney diseases associated with haematological cancers.

Authors:  Anirban Ganguli; Deirdre Sawinski; Jeffrey S Berns
Journal:  Nat Rev Nephrol       Date:  2015-06-02       Impact factor: 28.314

3.  Severe hypophosphataemia in T-cell lymphoblastic lymphoma.

Authors:  P Colman; B G Firkin; M B van der Weyden
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-08

4.  Tumour genesis syndrome: severe hypophosphatemia and hypokalemia may be ominous presenting findings in childhood acute myeloid leukaemia.

Authors:  Winnie Ky Chan; Kai On Chang; Wing Hung Lau
Journal:  Eur J Pediatr       Date:  2017-05-04       Impact factor: 3.183

5.  Life threatening hypophosphataemia in a patient with Philadelphia chromosome-positive chronic myelogenous leukaemia in acute blastic crisis.

Authors:  P Ra'anani; M Lahav; M Prokocimer; L Poles; E Theodor
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.